Alison Moore brings to Codexis significant experience as a biotechnology and pharmaceutical executive, including an extensive background in biomanufacturing. She is former Chief Technical Officer of Allogene Therapeutics, a pioneering clinical-stage company advancing CAR-T therapies. Prior to Allogene she spent a total of 20 years at Amgen, most recently as Senior Vice President, Process Development, and including roles in Supply Chain and Manufacturing. Dr. Moore also has experience at Genentech as a Director in Chemistry, Manufacturing and Controls, and Regulatory Affairs. Dr. Moore holds a bachelor’s degree in Pharmacology with Honors and a PhD in Cell Biology from Manchester University, England.

Georgia Erbez is a seasoned financial and operations executive, most recently serving as Chief Operating Officer at Walking Fish Therapeutics, a private B cell therapy company. Prior to that, she served as the Chief Financial Officer of Harpoon Therapeutics, a public T cell therapy company. Ms. Erbez also held the role of Chief Business Officer and Chief Financial Officer at Zosano Pharma Corp., and has served as Chief Financial Officer for Revolution Medicines, Asterias Biotherapeutics and Raptor Pharmaceuticals. Earlier in her career, Ms. Erbez held senior positions in investment banking, most recently at Cowen and Company and Jefferies. In addition, she was a Managing Director at Axiom Financial Partners, a life-sciences consulting firm. She currently serves as a member of the board of directors of Coherus BioSciences. Ms. Erbez holds a bachelor’s degree in international relations with an emphasis on economics from the University of California, Davis.

Britton joined Codexis in Jul 2024 and assumed responsibility for all commercial activities across RNA manufacturing and pharma biocatalysis. He came to us from Catalent Pharma Solutions, where he served as Vice President, Global Partners, overseeing all key strategic relationships. Prior to Catalent, Britton was Vice President of Business Development at Mayne Pharma, managing commercial activities and driving growth of their CDMO business, ultimately facilitating its $475M sale in 2022.

Throughout his career, Britton has demonstrated exceptional leadership in motivating teams, surpassing sales targets, and implementing innovative marketing strategies that fueled business growth. His ability to build strong client relationships and his strategic vision strengthened our team and advanced our goals.

Karen Frechou-Armijo is a forward-thinking human resources executive with more than two decades of experience driving transformative people strategies across life sciences and technology sectors. At Codexis, she leads all aspects of human capital strategy, including organizational design, talent acquisition and development, culture, and employee experience. Her leadership is instrumental in shaping Codexis’ high-performance, innovation-driven culture as the company scales and evolves in the synthetic biology space.

Prior to joining Codexis, Karen served as Vice President of Human Resources at Cepheid, where she guided the company through a period of hypergrowth, expanding the workforce more than sevenfold over five years. Known for her ability to align people strategy with business goals, Karen brings a track record of significant achievement and impact.